CAVA Group stock target raised by Argus on growth opportunities

Moderator - Tomas Kauer

Sep 11, 2024 - 15:00

CAVA Group stock target raised by Argus on growth opportunities

Tags:

Previous Article

Analyst bullish on Stoke Therapeutics stock following key epilepsy drug data

Exclusive-The identities of Wagner mercenaries lost in a Mali ambush revealed

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Moderator - Tomas Kauer

Related Posts

Relmada Therapeutics CFO buys $149,700 in company stock

Relmada Therapeutics CFO buys $149,700 in company stock

Moderator - Tomas... Sep 12, 2024

BlackRock and Microsoft to Launch $100bn AI Infrastructure Fund

BlackRock and Microsoft to Launch $100bn AI Infrastruct...

Moderator - Tomas... Sep 18, 2024

8 Business CRM Implementation Mistakes and How to Avoid Them

8 Business CRM Implementation Mistakes and How to Avoid...

Moderator - Tomas... Sep 18, 2024